Dion Morton

Dion Morton
Morton in February 2018
Alma materUniversity of Bristol
Known for
  • West Midlands Research Collaborative[1]
  • Pioneering collaborative research
  • Establishing a national infrastructure for clinical research in surgery
Medical career
Field
Institutions
Sub-specialtiesColorectal surgery
Websitewww.birmingham.ac.uk/staff/profiles/cancer-genomic/morton-dion.aspx Edit this at Wikidata

Dion Gregory Morton OBE is a leading colorectal surgeon at the University of Birmingham, where he has been Professor of Surgery since 2006. He was appointed Barling Chair of Surgery at the University of Birmingham in 2015. In addition he has served as Director of Clinical Research at the Royal College of Surgeons of England since 2011. In the latter role he has worked to establish a national infrastructure to support the development and dissemination of clinical trials in surgery.[2] He has championed the role of large-scale multi centre randomised controlled trials in informing best practice in surgery.[3]

Professor Morton is the Chief Investigator of the 'Fluoropyrimidine, Oxaliplatin and Targeted-Receptor pre-Operative Therapy for patients with high-risk, operable colon cancer' (FOxTROT) trial. This is a groundbreaking trial testing the efficacy of neoadjuvant chemotherapy in colon cancer, a cancer in which neoadjuvant therapy has traditionally had no role.[4]

Professor Morton has pioneered collaborative research in surgery, having championed and closely advised the foundation of the West Midlands Research Collaborative (WMRC), the first trainee-led research network in the UK.[1] Under his guidance the WMRC successfully delivered ROSSINI, the first-ever trainee-led multi-centre randomised controlled trial of a surgical intervention.[5] Subsequent, high-profile ongoing trials have included DREAMS[6] and ROCSS.[7]

He is also regional director of the 100,000 Genomes Project in the West Midlands.[8]

Morton was appointed Officer of the Order of the British Empire (OBE) in the 2020 Birthday Honours for services to innovation in the NHS.[9]

References

[edit]
  1. ^ a b http://wmresearch.org.uk/[full citation needed]
  2. ^ "We can't find that page".
  3. ^ "When an operating theatre becomes a lab". BBC News. 18 October 2013.
  4. ^ "FOxTROT trial".
  5. ^ Pinkney, T. D; Calvert, M; Bartlett, D. C; Gheorghe, A; Redman, V; Dowswell, G; Hawkins, W; Mak, T; Youssef, H; Richardson, C; Hornby, S; Magill, L; Haslop, R; Wilson, S; Morton, D; West Midlands Research Collaborative; ROSSINI Trial Investigators (2013). "Impact of wound edge protection devices on surgical site infection after laparotomy: Multicentre randomised controlled trial (ROSSINI Trial)". BMJ. 347: f4305. doi:10.1136/bmj.f4305. PMC 3805488. PMID 23903454.
  6. ^ Hamilton, Emma; Ravikumar, Reena; Bartlett, David; Hepburn, Elizabeth; Hwang, Mei-Ju; Mirza, Nazzia; Bahia, Sandeep S; Wilkey, Anthony; Bodenham Chilton, Helen; Handley, Kelly; Magill, Laura; Morton, Dion; West Midlands Research Collaborative (2013). "Dexamethasone reduces emesis after major gastrointestinal surgery (DREAMS)". Trials. 14: 249. doi:10.1186/1745-6215-14-249. PMC 3765230. PMID 23938028.
  7. ^ Bhangu, A; Futaba, K; Patel, A; Pinkney, T; Morton, D (2013). "Reinforcement of closure of stoma site using a biological mesh". Techniques in Coloproctology. 18 (3): 305–308. doi:10.1007/s10151-013-1001-3. PMID 23549713. S2CID 9096681.
  8. ^ "100,000 Genomes Project".
  9. ^ "No. 63135". The London Gazette (Supplement). 10 October 2020. p. B13.
[edit]
Wikimedia Commons has media related to Dion Morton.


Stub icon

This United Kingdom biographical article related to medicine is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Dion_Morton&oldid=1188208520"